Cigna's strong Q3 results indicate robust financial health, which is typically positive for stock prices. The stock's current low price compared to its 52-week high suggests a potential buying opportunity. The dismissal of merger rumors with Humana reduces uncertainty, which could positively impact investor sentiment.